BioCentury
ARTICLE | Company News

ExperGen, Thallion cancer news

July 13, 2009 7:00 AM UTC

Thallion said a binding arbitration proceeding has been started related to a dispute with ExperGen over TLN-232 (CAP-232), which Thallion (formerly Caprion Pharmaceuticals Inc.) licensed from ExperGe...